Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Semaglutide
Related studies linked through entity extraction aliases.
A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes
- Status
- COMPLETED
- Phase
- PHASE1
Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Renal Impairment on the Pharmacokinetics of NN9535
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide
- Status
- COMPLETED
- Phase
- PHASE2